Stock Comparison
ARGX vs URGN
argenx NV ADR and UroGen Pharma Ltd side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$2.38B
P/E (TTM)
32.7
—
Forward P/E
30.4
—
Price/Sales
10.0
12.6
Price/Book
6.4
16.9
EV/EBITDA
27.6
-2.7
Dividend Yield
—
—
Profitability
Net Margin
30.44%
-94.83%
Operating Margin
27.34%
-77.02%
Return on Equity
23.60%
-1481.00%
Return on Assets
11.60%
-18.10%
Growth (YoY)
Revenue Growth
59.30%
199.20%
Earnings Growth
95.20%
0.00%
Price & Risk
Beta
-0.0
1.6
52-Week High
$939.68
$49.00
52-Week Low
$652.43
$16.42
Analyst Target
$1,085.78
$58.25
Compare ARGX and URGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.